SCHERMA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 119.073
NA - Nord America 6.892
AS - Asia 3.235
SA - Sud America 483
AF - Africa 100
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 129.796
Nazione #
IT - Italia 117.309
US - Stati Uniti d'America 6.746
SG - Singapore 1.205
CN - Cina 1.051
SE - Svezia 448
BR - Brasile 385
VN - Vietnam 315
UA - Ucraina 291
DE - Germania 226
FI - Finlandia 206
GB - Regno Unito 192
FR - Francia 137
IN - India 99
HK - Hong Kong 88
CA - Canada 78
KR - Corea 77
BD - Bangladesh 65
NL - Olanda 65
TR - Turchia 65
AR - Argentina 40
IQ - Iraq 39
ES - Italia 38
MX - Messico 31
JP - Giappone 30
PL - Polonia 29
PK - Pakistan 28
AT - Austria 22
SA - Arabia Saudita 22
ZA - Sudafrica 22
MA - Marocco 20
UZ - Uzbekistan 20
EC - Ecuador 19
PH - Filippine 15
BE - Belgio 14
RU - Federazione Russa 14
IE - Irlanda 13
JO - Giordania 13
CZ - Repubblica Ceca 12
IR - Iran 12
CO - Colombia 11
NP - Nepal 11
ET - Etiopia 10
EG - Egitto 9
ID - Indonesia 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
VE - Venezuela 8
AU - Australia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
CL - Cile 6
MY - Malesia 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HR - Croazia 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
BB - Barbados 4
CI - Costa d'Avorio 4
DZ - Algeria 4
GE - Georgia 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
PY - Paraguay 3
RO - Romania 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
EU - Europa 2
GD - Grenada 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
NA - Namibia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
Totale 129.770
Città #
Cagliari 113.574
Uta 3.221
Ashburn 679
Singapore 597
Fairfield 589
Woodbridge 416
San Jose 414
Dallas 402
Chandler 360
Houston 307
Ann Arbor 279
Boardman 261
Nyköping 255
Seattle 248
Wilmington 208
Beijing 193
Cambridge 186
Jacksonville 154
Los Angeles 153
Council Bluffs 145
Dearborn 127
New York 120
Helsinki 119
Shanghai 112
Santa Clara 104
Hefei 87
Ho Chi Minh City 83
Hong Kong 79
Boston 74
The Dalles 74
Lauterbourg 71
Seoul 68
Hanoi 67
Munich 62
Nanjing 61
Dong Ket 45
Milan 41
Frankfurt am Main 39
Buffalo 35
Chennai 35
Orem 35
Rome 35
San Diego 34
Shenyang 34
São Paulo 33
Washington 32
Denver 31
Redwood City 29
Turku 29
Chicago 26
London 26
Amsterdam 24
Atlanta 24
Kocaeli 24
Tokyo 24
Toronto 23
Madrid 22
Guangzhou 21
Redondo Beach 21
Warsaw 21
Brooklyn 19
Montreal 19
Mountain View 19
Manchester 18
Tashkent 18
Tianjin 17
Nuremberg 16
Phoenix 16
Poplar 16
Baghdad 15
San Francisco 15
Sassari 15
Verona 15
Wuhan 15
Baltimore 13
Brussels 13
Dublin 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Stockholm 13
Da Nang 12
Lappeenranta 12
Mexico City 12
Rio de Janeiro 12
Vienna 12
Amman 11
Brasília 11
Casablanca 11
Changsha 11
Johannesburg 11
Addis Ababa 10
Arlington 10
City of London 10
Porto Alegre 10
Shenzhen 10
Tertenìa 10
Mumbai 9
Ningbo 9
Norwalk 9
Totale 125.218
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.675
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.904
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.382
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.358
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.345
Emotional profile of female rats showing binge eating behavior 3.261
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.095
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.971
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.962
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.900
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.880
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.850
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.824
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.722
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.600
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.598
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.513
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.480
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.399
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.389
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.355
Brain activity of anandamide: a rewarding bliss? 2.280
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.232
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.231
Animal Models of Eating Disorders 2.168
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.022
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.958
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.883
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.869
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.799
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.767
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.680
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.652
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.506
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.488
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.450
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.444
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.369
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.338
Cannabinoids and their therapeutic applications in mental disorders 1.274
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.254
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.161
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.146
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.077
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.063
Cannabinoid-opioid interaction in relapse to drug-seeking 1.060
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.058
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.037
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 1.034
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.030
Endocannabinoid system and opioid addiction: behavioural aspects 1.018
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 970
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 960
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 942
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 873
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 866
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 846
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 817
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 777
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 774
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 765
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 752
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 740
null 738
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 721
null 711
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 678
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 580
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 572
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 568
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 549
An overall view of the most common experimental models for multiple sclerosis 540
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 527
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 474
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 443
Modeling Anorexia Nervosa 394
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 378
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 345
Cannabinoids and reward: Interactions with the opioid system 329
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 291
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 281
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 258
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 195
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 169
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 168
Antibody conjugates in neuroblastoma: a step forward in precision medicine 148
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 122
Cannabinoid-nicotine interactions 48
Totale 130.120
Categoria #
all - tutte 165.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021980 0 0 0 0 0 0 0 0 0 0 0 980
2021/20227.549 998 507 284 662 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20267.049 749 510 777 635 551 531 979 306 482 899 465 165
Totale 130.120